Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arielle Mendel

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|October 6, 2023
N-terminal pro-brain natriuretic peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional studyKarim Sacre, Evelyne Vinet, Christian A Pineau, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
More than a 'Hundred Days War': Persistent SARS-CoV-2 infection in a patient with ANCA-associated vasculitisArielle Mendel, Ines Colmegna, Guillaume Bourque, et al.
Arthritis Care & Research|May 15, 2026
Artificial Intelligence-based Online Symptom Assessment Tools for Systemic Lupus Erythematosus (SLE) diagnosis: Patient PerspectivesOlivia A Stein, Jennifer Lf Lee, Evelyne Vinet, et al.
Rheumatology Advances in Practice|June 17, 2026
Values, preferences, and informational needs of individuals living with ANCA-associated vasculitis: a systematic reviewMats Junek, Seungwon Choi, Yuan Qi, et al.
Rheumatology International|January 22, 2026
Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosusOlivia A Stein, Jennifer L F Lee, Evelyne Vinet, et al.
Rheumatology (Oxford, England)|June 28, 2019
Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitisEline Houben, Arielle Mendel, Joost W van der Heijden, et al.
The Journal of Rheumatology|February 2, 2022
COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to ControlsLihi Eder, Ruth Croxford, Aaron M Drucker, et al.
Arthritis Care & Research|September 6, 2021
Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 TestingLihi Eder, Ruth Croxford, Aaron M Drucker, et al.
Lupus Science & Medicine|January 30, 2025
Medication-related hospitalisations in patients with SLEMichèle Stanciu, Joo-Young Esther Lee, Emily G McDonald, et al.
The Journal of Rheumatology|December 1, 2025
A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus ErythematosusSarah Aly, Gilda Parastandehchehr, Sasha Bernatsky, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|October 6, 2023
N-terminal pro-brain natriuretic peptide is a biomarker for cardiovascular damage in systemic lupus erythematous: a cross-sectional studyKarim Sacre, Evelyne Vinet, Christian A Pineau, et al.
Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal Officiel De L'Association Pour La Microbiologie Medicale Et L'Infectiologie Canada|November 7, 2022
More than a 'Hundred Days War': Persistent SARS-CoV-2 infection in a patient with ANCA-associated vasculitisArielle Mendel, Ines Colmegna, Guillaume Bourque, et al.
Arthritis Care & Research|May 15, 2026
Artificial Intelligence-based Online Symptom Assessment Tools for Systemic Lupus Erythematosus (SLE) diagnosis: Patient PerspectivesOlivia A Stein, Jennifer Lf Lee, Evelyne Vinet, et al.
Rheumatology Advances in Practice|June 17, 2026
Values, preferences, and informational needs of individuals living with ANCA-associated vasculitis: a systematic reviewMats Junek, Seungwon Choi, Yuan Qi, et al.
Rheumatology International|January 22, 2026
Patient perspectives on clinical trial participation for novel advanced therapies: a focus group study in systemic lupus erythematosusOlivia A Stein, Jennifer L F Lee, Evelyne Vinet, et al.
Rheumatology (Oxford, England)|June 28, 2019
Prevalence and management of cardiovascular risk factors in ANCA-associated vasculitisEline Houben, Arielle Mendel, Joost W van der Heijden, et al.
The Journal of Rheumatology|February 2, 2022
COVID-19 Hospitalizations, Intensive Care Unit Stays, Ventilation, and Death Among Patients With Immune-mediated Inflammatory Diseases Compared to ControlsLihi Eder, Ruth Croxford, Aaron M Drucker, et al.
Arthritis Care & Research|September 6, 2021
Understanding COVID-19 Risk in Patients With Immune-Mediated Inflammatory Diseases: A Population-Based Analysis of SARS-CoV-2 TestingLihi Eder, Ruth Croxford, Aaron M Drucker, et al.
Lupus Science & Medicine|January 30, 2025
Medication-related hospitalisations in patients with SLEMichèle Stanciu, Joo-Young Esther Lee, Emily G McDonald, et al.
The Journal of Rheumatology|December 1, 2025
A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus ErythematosusSarah Aly, Gilda Parastandehchehr, Sasha Bernatsky, et al.
Pageof 4